News
TipRanks on MSN22d
Novartis’s treatment of leishmaniasis granted FDA orphan designationNovartis’s (NVS) parasite-selective proteasome inhibitor with potent activity against kinetoplastid parasites was granted FDA orphan designation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback